<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02398955</url>
  </required_header>
  <id_info>
    <org_study_id>BELLINI01</org_study_id>
    <nct_id>NCT02398955</nct_id>
  </id_info>
  <brief_title>Biomime Stent in All-comers PCI Patients Registry</brief_title>
  <acronym>BELLINI</acronym>
  <official_title>Biomime Biosorbable Polymer Sirolimus-ELuting Stent in alL-comers patIeNts Treated With Percutaneous Coronary Interventions: the BELLINI Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Ospedaliero Universitaria Maggiore della Carita</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda Ospedaliero Universitaria Maggiore della Carita</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Biomime stent is a novel sirolimus-eluting stent (SES) (Meril Life Sciences Pvt. Ltd.,
      Gujarat, India) with an ultra-thin stent platform (65 Î¼m) and a biodegradable polymer
      licensed for the treatment of de novo coronary lesions. However no data regarding the
      efficacy and safety of this stent in an &quot;all-comers&quot; patient population treated with
      percutaneus coronary interventions (PCI) have been published so far. In this registry the
      investigators aimed to collect clinical and angiographic information about an extensive
      &quot;all-comers&quot; employ of this novel stent.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2014</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">June 2016</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>target vessel revascularization</measure>
    <time_frame>1 year</time_frame>
    <description>rate of target vessel percutaneous or surgical reintervention for recurrent symptoms or inducible ischemia at follow up testes</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>death from any cause</measure>
    <time_frame>1 year</time_frame>
    <description>death from any cause after the procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cardiac death</measure>
    <time_frame>1 year</time_frame>
    <description>death form cardiac causes (reinfarction, sudden cardiac death, death during coronary reintervention, heart failure, arrhythmias)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>reinfarction</measure>
    <time_frame>1 year</time_frame>
    <description>reinfarction in the myocardial region supplied by the treated coronary artery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>target lesion revascularization</measure>
    <time_frame>1 year</time_frame>
    <description>rate of target lesion percutaneous reintervention for recurrent symptoms or inducible ischemia at follow up testes</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>Study cohort</arm_group_label>
    <description>All comers patients with coronary artery disease treated with percutaneous coronary intervention and at least one Biomime stent</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>percutaneous coronary intervention</intervention_name>
    <description>percutaneous coronary angioplasty with implantation of at least one Biomime stent</description>
    <arm_group_label>Study cohort</arm_group_label>
    <other_name>Biomime stent</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All comers patients with coronary artery disease treated with percutaneous coronary
        intervention and a Biomime stent, age &gt; 18 years
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  any coronary artery disease treated with percutaneous coronary intervention and a
             Biomime stent

        Exclusion Criteria:

          -  patients &lt;18 years old
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alessandro Lupi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Azienda Ospedaliero Universitaria Maggiore della Carita</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alessandro Lupi, MD</last_name>
    <phone>+3903213733236</phone>
    <email>lupialessandro1@tin.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Azienda Ospedaliero Universitaria Maggiore della Carita</name>
      <address>
        <city>Novara</city>
        <state>Piedmont</state>
        <zip>28100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alessandro Lupi, M.D.</last_name>
      <phone>+393495643838</phone>
      <email>lupialessandro1@tin.it</email>
    </contact>
    <investigator>
      <last_name>Alessandro Lupi, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 22, 2015</study_first_submitted>
  <study_first_submitted_qc>March 25, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 26, 2015</study_first_posted>
  <last_update_submitted>March 25, 2015</last_update_submitted>
  <last_update_submitted_qc>March 25, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 26, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Azienda Ospedaliero Universitaria Maggiore della Carita</investigator_affiliation>
    <investigator_full_name>Lupi Alessandro</investigator_full_name>
    <investigator_title>Dr Alessandro Lupi</investigator_title>
  </responsible_party>
  <keyword>Drug-Eluting Stents</keyword>
  <keyword>Coronary Artery Disease</keyword>
  <keyword>Sirolimus</keyword>
  <keyword>Absorbable Implants</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sirolimus</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

